Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
PAIM
RRAM
UBS AM's BXC Position: Q2 2026 in Review
UBS AM reduced its BlueLinx (BXC) stake by 96% in Q2 2026, selling an estimated $737K and leaving 519 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.
UBS AM first reported a position in BXC in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.91M in Q4 2024. 158 funds tracked by Wall St. Rank hold BXC as of Q2 2026.
- UBS AM held 519 shares of BlueLinx worth $32.1K as of Q2 2026.
- UBS AM sold 13,634 BlueLinx shares in Q2 2026, an estimated $737K.
- BlueLinx made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3033 holding.
- UBS AM first reported a position in BlueLinx in Q2 2022 and has held it in 17 quarters since.
- UBS AM's BlueLinx position peaked at $1.91M in Q4 2024.
- 158 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.